DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/w8pn9w/global_outlook_of) has announced the addition of the "Global Outlook of Antibacterial Market Beyond 2012 - 2016" report to their offering.
This report examines each of the antibacterial classes in turn, assessing the market potential and application in hospital and community-acquired infections.
The report assesses the overall antibacterial market, key classes and the drivers and resistors influencing their prescription. The report provides an overview of key products in each category, summarizing their clinical efficacy and marketing position. The overview of the current market is given in terms of segmentation and by leading players and their products and analyzes market trends
Combating resistance will require a multi-pronged approach: one focused on prevention and the more judicious use of antibiotics, but one also focused on the discovery and development of not just new antibiotics, but new antibiotics with novel potential to inhibit bacterial growth, reproduction, and resistanceeither through novel mechanisms of action or through the inhibition of new targets. Several companies featured in this report are pursuing the discovery and development of new antibiotic compounds. However, far too many of the new compounds are simply improved analogues of already existing compounds, which means that they probably won't be presenting much of a challenge to the bacterial world with respect to combating resistance.
Key Topics Covered:
1 EXECUTIVE SUMMARY
2 BACTERIAL CLASSIFICATIONS
2.1 New Classes
2.2 Antibacterial Target Mechanism
3 INTRODUCTION TO BACTERIAL DISEASES
3.1 Group A Streptococcus (GAS)
3.2 Group B Streptococcus (GBS)
3.3 Streptococcus pneumonia
3.4 Haemophilus Influenza
3.5 Neisseria Meningitides
3.6 Methicillin Resistant Staphylococcus Aureus (MRSA)
4 KEY DRIVERS
4.1 Potential for Clinical Success
5 KEY RESISTORS
5.1 Over-prescription
5.2 Economy impact Resistance
5.3 Acute Use of Antibiotics
6 THE MARKET
6.1 Global Antibacterial Market
6.2 Antibacterial Major Players in 2012
6.3 Antibacterial market in Asia-Pacific Region
6.4 Antibacterial market in Europe
6.5 Antibacterial market in Middle-east and North Africa
6.6 Antibacterial market in India
6.7 Leading Indian Antibacterial drugs manufacturing companies
6.8 Antibacterial Agents by 2012
6.9 Future Scope & global Antibacterial Sales Forecast
7 LEADING ANTIBACTERIAL DRUG CLASSES
7.1 Aminoglycosides
7.2 Carbapenems
7.3 Cephalosporins
7.4 Glycopeptide
7.5 Ketolide
7.6 Lipopeptide
7.7 Macrolides
7.8 Penicillins
7.9 Oxazolidinones
7.10 Pleuromutilins
7.11 Quinolone
8 LEADING BRANDS
8.1 Current Marketed Antibacterial Drugs
9 CASE STUDIES
9.1 Cadila Healthcare Limited.
9.2 Dishman Pharmaceuticals & Chemicals Limited.
9.3 Divi's Laboratories Limited.
9.4 Hikal Limited.
9.5 Natco Pharma.
Companies Mentioned
- AstraZeneca
- Abbott
- Aventis
- Bayer
- BMS
- Cubist
- Eli Lily
- GSK
- J&J
- King Pharmaceuticals
- Merck & co
- Pfizer
- Wyeth
- Roche
For more information visit http://www.researchandmarkets.com/research/w8pn9w/global_outlook_of